Physician

Erin Ashton Salinas, M.D.

According to 2025 Medicare claims, Erin Salinas, M.D. (NPI: 1245551845) practices gynecologist/oncologist in the Portland-Vancouver-Hillsboro, OR-WA market, with the plurality of this provider's patient population coming from Clackamas, OR. This provider's primary affiliated billing organization is NORTHWEST CANCER SPECIALISTS PC (NPI: 1407828114; TIN: 931280206) and primary practice location at 97227-1800.

Salinas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 213 traditional Medicare patients, billed 55,931 HCPCS/CPT codes, and received $955,298 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 553 prescription claims across 122 beneficiaries totaling $1,561,609 in drug costs, led by Zejula (Niraparib Tosylate). 2023 DME data shows 12 claims. Open Payments data shows 17 records totaling $75,242. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $8,622 to $955,298. Similarly, Part D prescription costs have moved sharply higher in recent years, from $15,450 to $1,561,609. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	32	1,126	$8,622
2018	217	24,805	$273,889
2019	237	48,627	$614,611
2020	135	21,191	$174,774
2021	209	52,111	$640,164
2022	190	51,442	$480,123
2023	208	50,672	$577,152
2024	213	55,931	$955,298

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	34	84	$15,450
2016	N/R	18	$201
2017	24	77	$4,776
2018	82	316	$104,237
2019	93	451	$448,063
2020	75	320	$505,662
2021	105	427	$1,051,934
2022	98	434	$693,607
2023	127	496	$191,852
2024	122	553	$1,561,609

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$516
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	75	159	$97
86304	Immunologic analysis for detection of tumor antigen, quantitative; ca 125	67	289	$20
99459	Pelvic exam	51	62	$19
36415	Insertion of needle into vein for collection of blood sample	63	130	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	52	316	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Zejula	Niraparib Tosylate	55	1,538	$970,421
Lynparza	Olaparib	35	1,120	$372,877
Eliquis	Apixaban	45	1,540	$30,234
Enoxaparin Sodium	Enoxaparin Sodium	14	267	$1,530
Estradiol (Twice Weekly)	Estradiol	13	574	$1,366

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$434	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	9	$74,808	GlaxoSmithKline, LLC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Erin Ashton Salinas, M.D.?

Tedicare shows public-source Medicare data for Erin Ashton Salinas, M.D. (NPI 1245551845), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Erin Ashton Salinas, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Erin Ashton Salinas, M.D.?

Erin Ashton Salinas, M.D. is linked to NORTHWEST CANCER SPECIALISTS PC (billing NPI 1407828114) in the available physician profile data.

Does Erin Ashton Salinas, M.D. have Open Payments data?

Erin Ashton Salinas, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.